Offices:

Washington DC Office
1101 Pennsylvania Ave.
Suite 600
Washington DC 20004
Telephone: 202-756-2972

Miami Office
1111 Brickell Avenue
11th Floor
Miami, FL 33131
Telephone: 305-913-7199

Fort Lauderdale Office
110 E. Broward Blvd.
Suite 1700
Fort Lauderdale, FL 33301
Telephone: 954-315-3934

Avandia Heart Risks News

Glaxo Subpoenaed On Avandia in U.S.

- KPVI.com

11/16/2010 - The state of Utah is suing GlaxoSmithKline on allegations the company misleadingly marketed its drug Avandia as a wonder drug for Type 2 diabetes.

Assistant Attorney General Robert Morton tells KSL-TV the state doesn't believe the company's claim that it has science to back it up.

Some studies have tied Avandia to a higher risk of heart
problems. In September, European regulators ordered Avandia off the market, while U.S. regulators restricted which patients could get it.

Utah's lawsuit says the company defrauded the state Medicaid program of $7.8 million, which is what it has spent on Avandia.

GlaxoSmithKline did not return a phone call from KSL-TV seeking comment.

Avandia Side Effects Cases Still Being Accepted:

The lawyers of Ennis & Ennis, P.A. are still accepting Avandia side effects cases and have extensive experience representing plaintiffs in Avandia lawsuits nationwide.

If you or a loved one have experienced an Avandia heart attack, or Avandia stroke, Avandia congestive heart failure, Avandia cardiovascular disease or if you have lost a loved one to an Avandia death you may be entitled to compensation. Contact the Avandia lawyers of Ennis & Ennis, P.A. today about an Avandia lawsuit. Call us toll free for a free, confidential case evaluation or fill out our online Avandia case evaluation form

Case Evaluation Form
*Required

Your Full Name:*

E-mail address:*

Mailing address:*

City:*

State:*

Zip:* (5 digit Zip Code)

Phone number:*
(123-123-1234)

Age:*

When did you begin and end using Avandia?

Please list any injuries:

If you have been injured as a result of Avandia side effects we recommend that you notify the FDA
FDA MEDWATCH FORM